Search

everythinglearnresearchcommunity

for

Search:↓

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

A unique gene mutation causes vitamin D-resistant rickets without causing hair loss.

mTORC2 is crucial for healthy skin barrier by regulating lipids and filaggrin.

CK 15, follistatin, and Bmi-1 can help differentiate basal cell carcinoma from squamous cell carcinoma.

Pilomatrixoma involves abnormal hair keratin production and cell death, causing debris and cysts.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Noggin promotes skin tumors by activating Wnt and Shh pathways.

Acitretin effectively prevented skin cancer in a patient with late-onset Rothmund-Thomson syndrome.

New RIPK4 gene mutations were found to cause a type of skin and limb birth defect.

Lack of vitamin D receptor increases skin tumor risk by boosting hedgehog signaling.

Trichoblastic carcinoma may be a distinct type of skin cancer different from basal cell carcinoma.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Lhx2 helps retinal cells respond to signals for eye development.

Trichilemmoma, BCC, and SCC tumors have different stem cell marker expressions.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Trichoepithelioma and desmoplastic trichoepithelioma have distinct features that can be identified using reflectance confocal microscopy.

Patched1 helps prevent tumors by controlling cell growth.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

ROR2 is crucial for hair follicle stem cell maintenance and self-renewal.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

FTase and GGTase-I are essential for skin keratinocyte health.

A new gene mutation causes vitamin D resistance and rickets, treatable with calcium therapy.

Fzd2 is important for skin and hair development through various signaling ways.